PrecISE: Precision Interventions for Severe and/or Exacerbation-Prone Asthma Network (adolescents, age 12-18)
Primary Objective
Objectives for PrecISE (Precision Interventions for Severe and/or Exacerbation-Prone Asthma) clinical study: (1) To identify novel therapies that work in biomarker-defined subgroups of moderate and severe asthmatic participants; and (2) To optimize the subgroups targeted for treatment by refining the biomarkers and subgroup definitions.
Description
PrecISE: A breath of fresh air from the National Institutes of Health (NIH). Severe asthma is different for everyone. That is why we need you for PrecISE. Join a severe asthma study unlike any other. Have the opportunity to try many different therapies not available otherwise. Talk with an asthma specialist and be compensated for your time. If you choose, you can receive study provided baseline asthma therapies and asthma controller medication. Multiple treatments will be tested in a placebo controlled randomized trial. In this (12-18) age group, interventions include MCT supplement and Broncho-Vaxom. Each participant will participate in at least 2 treatment periods (up to 5 treatment periods). Treatment periods will each last 16 weeks and will require monthly visits.
Details
Locations
Childrens Hospital Colorado
Principal Investigator
Stanley Szefler
Study ID
Protocol Number: 19-0619
More information available at ClinicalTrials.gov: NCT04129931
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers